abstract - studentsrepo.um.edu.mystudentsrepo.um.edu.my/3756/2/front_part.pdf · ii abstract...
TRANSCRIPT
ii
ABSTRACT
Candida species is an opportunistic microorganism residing in the human oral cavity.
There is increasing prevalence of candidal infections in the oral cavity largely because
of the increasing size of the population at risk. The rise in diagnosed cases of oral
candidiasis is also due to the immunosuppressive effect of prescribed antifungal agents
on resistant hosts. The ability of Candida species to adhere on mucosal tissues and/or
denture surfaces, and the production of hydrolytic enzymes along with defective host
immunity are among the known key factors of invasions and pathogenesis of oral
candida. Although Candida albicans remains as the most pathogenic organism, the
emergence of non-Candida albicans Candida (NCAC) species with reduced
susceptibility to prescribed antifungal agents has prompted efforts to study antifungal
agents from natural sources. Plants have long been known to possess medicinal values
and are rich in chemical constituents that can be used in the development of antifungal
products. Initially, seven local plants were systematically screened for their antifungal
activity and two of them - Brucea javanica L. and Piper betle L. were selected based on
their positive antifungal activities on seven Candida species tested. The specific
objectives of this study were; (i) to determine the minimum inhibition concentration
(MIC) and minimum fungicidal concentration (MFC) values of the extracts, (ii) to
investigate the growth inhibitory effect of the extracts based on changes in the pattern of
growth profile of each Candida species, (iii) to investigate the influence of extracts on
adherence mechanisms which include the non-specific and specific bindings, (iv) to
investigate any morphological changes of the cells following treatment with the extracts,
and (v) to explore the differential expressions of multigene family of secreted aspartyl
proteinases (SAPs) and hyphal cell wall protein 1 (HWP1).
iii
Candida species purchased from the American Types Culture Collection (ATCC) were
Candida albicans ATCC 14053, Candida dubliniensis ATCC MYA-2975, Candida
glabrata ATCC 90030, Candida krusei ATCC 14243, Candida lusitaniae ATCC 64125,
Candida parapsilosis ATCC 22019 and Candida tropicalis ATCC 13803. Growth
inhibitory responses of the Candida species to the extracts include determination of the
MIC and MFC, while effect on the growth curve was determined based on
spectrophotometric assay. Deviations in the doubling time (g) and specific growth rates
(µ) were computed as percentage to extract-treated cells relative to that of the total cells
in the absence of extracts. In addition, the anti-adherence effect of the B. javanica and P.
betle extracts which included study on the cell-surface hydrophobicity (CSH) and
specific bindings on pellicles, ultrastructure and the regulations of SAP1-10 and HWP1
were also analysed. 0.12% w/v chlorhexidine gluconate-containing mouthrinse was
used as a reference.
In preliminary screening, the diameter of inhibition zone (DIZ) values showed that B.
javanica and P. betle aqueous extracts exhibited a wide range of antifungal activities
over the seven Candida species with C. dubliniensis identified as the most sensitive. Of
the seven Candida species, C. tropicalis showed the highest growth rates (0.319 ± 0.002
h-1
) while the others were in the range of 0.141 ± 0.001 to 0.265 ± 0.005 h-1
. This
indicated that different species of candida reproduce at different rate. In the presence of
extracts, the lag and log phases were extended and shifted to the right. This resulted in
the deviations of the g- and µ-values, indicating that the extracts may have exerted
fungistatic activity towards the candidal cells. Growth kinetics of the candidal species
was also elucidated based on colony forming unit (CFU) enumeration. Different
Candida species have shown different CSH values and adhering capacity to the pellicle.
iv
In view of the CSH, C. krusei, C. dubliniensis and C. tropicalis showed the highest
adsorption to hexadecane at 30.23%, 26.19% and 19.70%, respectively, while the others
were much lower within the range of 7% to 10%. The CSH of all Candida species were
significantly affected by these two extracts (P < 0.05), with B. javanica exhibiting more
than 60% reduction of CSH than P. betle. Specific bindings of the candidal cells on the
pellicles were also shown to be affected by the treatment of extracts. Exposure to P.
betle-treated pellicle drastically reduced the adhering capacity of three out of seven
candidal species by more than 50% (C. tropicalis 86.02%, C. albicans 61.41% and C.
krusei 56.34%). Pellicles treated with B. javanica exhibited similar effect on C.
tropicalis (89.86%), C. lusitaniae (89.66%), C. albicans (79.74%), C. glabrata (76.85%)
and C. krusei (67.61%). Comparatively, the adherence interference effect of B. javanica
towards the candidal cells was slightly higher than P. betle. In addition to the growth
inhibitory and anti-adherence effects, physical changes in the cell walls of Candida
species were also demonstrated following treatment of the candidal cells with the
extracts. The expressions of SAP1-10 and HWP1 were affected by the extracts treatment,
suggesting that the extracts have successfully penetrated and disrupted the intrinsic
environment of the cells. The genes seemed to be suppressed and this may then revoke
the pathogenesis of oral Candida.
As a conclusion, B. javanica and P. betle exhibited antifungal activities towards the
seven oral Candida species tested. Data from this study strongly suggest the fungistatic
and growth inhibitory effects of the extracts. Thus, B. javanica and P. betle extracts may
be considered as promising adjuncts in oral health products.
v
ABSTRAK
Spesies Candida merupakan mikroorganisma oportunis yang menetap di dalam mulut
manusia. Jangkitan Candida dalam mulut (oral kandidiasis) biasanya berlaku kepada
golongan yang berisiko masalah kesihatan. Peningkatan kes kandidiasis juga berpunca
daripada kesan imunosupresif agen antikulat yang diberikan kepada hos secara
konsistan. Keupayaan spesies Candida untuk melekat ke atas tisu mukosa dan/atau
permukaan dentur, dan penghasilan enzim-enzim hidrolitik ketika sistem imunisasi
tidak sempurna antara faktor utama kolonisasi dan patogenesis bagi spesies Candida.
Walaupun Candida albicans masih kekal sebagai organisma patogen, tetapi kemunculan
spesies Candida selain C. albicans yang rintang terhadap agen antikulat telah
mendorong usaha untuk mengkaji agen antikulat yang baru daripada sumber semulajadi.
Tumbuh-tumbuhan telah lama diketahui mempunyai nilai perubatan dan kaya dengan
juzuk kimia yang boleh digunakan dalam pembangunan produk-produk antikulat.
Dalam penyelidikan ini, tujuh spesies tumbuhan tempatan telah disaring secara
sistematik bagi mengetahui aktiviti antikulatnya, dan dua daripadanya iaitu Brucea
javanica L. dan Piper betle L. telah dipilih untuk kajian seterusnya kerana menunjukkan
potensi aktiviti antikulat ke atas tujuh spesies Candida yang diuji. Objektif khusus
penyelidikan ini adalah untuk (i) menentukan kepekatan perencatan minimum (MIC)
dan kepekatan fungisidal minimum (MFC) bagi ekstrak yang diuji, (ii) mengkaji kesan
perencatan ekstrak terhadap pertumbuhan sel Candida, (iii) mengkaji pengaruh ekstrak
ke atas mekanisma perlekatan spesies Candida meliputi pengikatan khusus dan bukan
khusus, (iv) mengkaji sebarang perubahan struktur permukaan sel Candida selepas
rawatan ekstrak diberikan, dan (v) meneroka perbezaan ekspresi gen SAP (SAP1-10)
dan HWP1 di bawah pengaruh ekstrak.
vi
Tujuh spesies Candida yang telah dibeli daripada American Types Culture Collection
(ATCC) adalah Candida albicans ATCC 14053, Candida dubliniensis ATCC MYA-
2975, Candida glabrata ATCC 90030, Candida krusei ATCC 14243, Candida
lusitaniae ATCC 64125, Candida parapsilosis ATCC 22019 dan Candida tropicalis
ATCC 13803. Tindak balas perencatan pertumbuhan tujuh spesies Candida terhadap
ekstrak merangkumi penentuan MIC and MFC, manakala kesan ke atas lengkok
pertumbuhan ditentukan dengan kaedah asai spektrofotometri. Perubahan bagi
peratusan masa ganda dua (g) dan kadar pertumbuhan spesifik (µ) selepas rawatan
ekstrak berbanding jumlah sel sebelum rawatan ekstrak ditentukan. Kesan ekstrak B.
javanica dan P. betle terhadap mekanisma perlekatan, struktur morfologi sel, dan aturan
expresi gen SAP1-10 dan HWP1 turut dikaji. 0.12% w/v chlorhexidine digluconate
diguna sebagai kawalan positif.
Dalam ujian penyaringan awal, diameter zon perencatan menunjukkan ekstrak B.
javanica dan P. betle mempunyai kepelbagaian aktiviti antikulat ke atas tujuh spesies
Candida yang diuji, di mana C. dubliniensis merupakan spesies yang paling sensitif
berbanding yang lain. C. tropicalis merupakan spesies yang mempunyai kadar
pertumbuhan yang tinggi (0.319 ± 0.002 h-1
), manakala spesies Candida lain sekitar
julat 0.141 ± 0.001 to 0.265 ± 0.005 h-1
. Ini menunjukkan bahawa spesies yang berbeza
dalam genus Candida mempunyai kebolehulangan yang berbeza. Dengan kehadiran
ekstrak, fasa-fasa lag dan log telah diperluas dan beralih ke kanan. Ini menunjukkan
ekstrak mempunyai aktiviti fungistatik. Kesan ekstrak ke atas kinetik pertumbuhan
spesies Candida juga dikaji berdasarkan jumlah pembentukan koloni unit (CFU). C.
krusei, C. dubliniensis dan C. tropicalis mempunyai kapasiti penyerapan hexadecane
yang tinggi masing-masing pada 30.23%, 26.19% dan 19.70%, berbanding yang lain
vii
dalam julat 7% hingga 10%. Kehidrofobian permukaan sel bagi semua spesies Candida
telah terjejas berikutan rawatan ekstrak yang diberi (P < 0.05), di mana ekstrak B.
javanica lebih berkesan dengan 60% pengurangan kehidrofobian berbanding ekstrak P.
betle. Kapasiti pengikatan spesifik setiap spesies Candida ke atas pelikel turut terjejas
dengan rawatan kedua-dua ekstrak yang diberikan. Pendedahan sel ke atas pelikel yang
dirawat ektrak P. betle telah mengurangkan kapasiti pelekatan tiga daripada tujuh
spesies Candida lebih daripada 50% (C. tropicalis 86.02%, C. albicans 61.41% dan C.
krusei 56.34%). Pelikel yang dirawat dengan ekstrak B. javanica menunjukkan kesan
yang sama ke atas C. tropicalis (89.86%), C. lusitaniae (89.66%), C. albicans (79.74%),
C. glabrata (76.85%) dan C. krusei (67.61%). Secara perbandingan, kesan gangguan
pelekatan yang dikenakan ekstrak B. javanica terhadap sel Candida sedikit tinggi
daripada ekstrak P. betle. Di samping kesan perencatan pertumbuhan dan anti-pelekatan,
perubahan fizikal pada dinding sel spesies Candida juga kelihatan selepas rawatan
ekstrak diberi. Ekpresi gen SAP1-10 dan HWP1 juga terjejas menunjukkan bahawa
ekstrak berjaya menembusi membran sel dan membeku persekitaran intrinsik sel-sel.
Gen-gen ini kelihatannya ditindas dan menafikan proses patogenesis spesies Candida.
Kesimpulannya, ekstrak B. javanica dan P. betle mempunyai kesan anti-kulat terhadap
tujuh spesies Candida yang diuji. Data yang diperoleh daripada kajian ini juga
membuktikan bahawa ekstrak B. javanica dan P. betle mempunyai aktiviti fungistatik
dan kesan perencatan pada kepekatan yang lebih tinggi. Justeru, kedua-dua tumbuhan
tempatan ini berpotensi untuk pembangunan sebagai agen antikulat khususnya dalam
penghasilan produk-produk kesihatan mulut.
viii
ACKNOWLEDGEMENT
This project has worked out smoothly through the tireless dedication of talented
workaholics:
I could not have done this work without the help of several people who contributed to it
directly or indirectly. First and foremost, I would like to express my gratitude to my
supervisors, Dr. Wan Himratul Aznita Wan Harun and Assoc. Prof. Dr. Fathilah
Abdul Razak for giving me the opportunity to work on this interesting project. Their
continuous support and guidance, the unlimited enthusiasm and the numerous helpful
discussions were the cornerstones of this project.
I would like to thank the staff of the Department of Oral Biology, Faculty of Dentistry,
University of Malaya, the staff of Electron Microscopy Unit, Faculty of Medicine,
University of Malaya, and the staff of Microscopy Unit, Institute of Bioscience,
Universiti Putra Malaysia for their assistance throughout the project. I want to thank all
former and current members of the lab for all the lively discussions that have created an
atmosphere, which made the whole work fun!
I am also thankful for the financial supports from the University of Malaya Research
Grant (RG095/09HTM), Postgraduate Research Fund (PS160/2010B), and the
Malaysian Government Scholarship (MyBrain15).
Special thanks to my parents who tempered each other’s advice to give me strength and
endless support throughout this life.
ix
LIST OF CONTENTS PAGE
ABSTRACT i
ABSTRAK v
ACKNOWLEDGEMENT viii
LIST OF CONTENTS ix
LIST OF FIGURES xvii
LIST OF TABLES xx
LIST OF ABBREVIATIONS xxi
CHAPTER ONE: INTRODUCTION AND OBJECTIVES
1.1 Introduction 1
1.2 Objectives 4
CHAPTER TWO: LITERATURE REVIEW
2.1 The Oral Cavity and Its Indigenous Microbial 5
2.2 The Genus Candida 5
2.2.1 Biology and Taxonomy 5
2.2.2 General Morphology 6
2.2.3 Structures and Functions of Cell Wall 7
2.3 Normal Microbial Flora 13
2.4 Transition of the Normal Flora to Pathogenic Flora 13
2.5 Types of Candida Species 14
2.5.1 Candida albicans 14
2.5.2 Candida dubliniensis 15
2.5.3 Candida glabrata 16
x
LIST OF CONTENTS PAGE
2.5.4 Candida krusei 17
2.5.5 Candida lusitaniae 18
2.5.6 Candida parapsilosis 19
2.5.7 Candida tropicalis 20
2.6 Emergence of the Non-Candida albicans Candida Species 21
2.7 Oral Candidiasis 21
2.7.1 Classification of Oral Candidiasis 22
2.7.2 Predisposing Factors to Oral Candidiasis 22
2.7.2.1 Local Host Factors 22
2.7.2.2 Systemic Factors 23
2.7.2.3 Iatrogenic Factors 24
2.7.3 Denture Wearing Associated with Oral Candidiasis 26
2.8 Virulence Factors 27
2.8.1 Adherence Mechanisms 27
2.8.1.1 Specific Adhesion: Acquired Pellicles 27
2.8.1.2 Non-Specific Adhesion: Cell Surface Hydrophobicity 29
2.8.2 Virulence-Associated Genes in Candida Species 30
2.8.2.1 Adhesin-like Hyphal Cell Wall Protein 1 (Hwp1) 31
2.8.2.2 Secreted Aspartyl Proteinases (Saps) 32
2.9 Chemical-based Antimicrobial: Chlorhexidine gluconate 34
2.10 Plant-based Antimicrobial: An Alternative to Antifungal Agents 34
2.11 Types of Plant Species 35
2.11.1 Brucea javanica Linn. 35
2.11.1.1 General Information 35
xi
LIST OF CONTENTS PAGE
2.11.1.2 The Uses of Brucea javanica (L.) Merr. 36
2.11.1.3 The Chemical Constituents of Brucea javanica (L.) Merr. 36
2.11.2 Centella asiatica Linn. 37
2.11.2.1 General Information 37
2.11.2.2 The Uses of Centella asiatica L. 38
2.11.2.3 The Chemical Constituents of Centella asiatica L. 38
2.11.3 Garcinia mangostana Linn. 39
2.11.3.1 General Information 39
2.11.3.2 The Uses of Garcinia mangostana L. 39
2.11.3.3 The Chemical Constituents of Garcinia mangostana L. 40
2.11.4 Mangifera indica Linn. 41
2.11.4.1 General Information 41
2.11.4.2 The Uses of Mangifera indica L. 41
2.11.4.3 The Chemical Constituents of Mangifera indica L. 42
2.11.5 Piper betle Linn. 43
2.11.5.1 General Information 43
2.11.5.2 The Uses of Piper betle L. 43
2.11.5.3 The Chemical Constituents of Piper betle L. 44
2.11.6 Piper sarmentosum Roxb. 44
2.11.6.1 General Information 44
2.11.6.2 The Uses of Piper sarmentosum Roxb. 45
2.11.6.3 The Chemical Constituents of Piper sarmentosum Roxb. 46
2.11.7 Psidium guajava Linn. 46
2.11.7.1 General Information 46
xii
LIST OF CONTENTS PAGE
2.11.7.2 The Uses of Psidium guajava L. 47
2.11.7.3 The Chemical Constituents of Psidium guajava L. 48
CHAPTER THREE: MATERIALS AND METHODS
3.1 Materials 49
3.1.1 Plant Samples 49
3.1.2 Candida Species 49
3.1.3 Culture Media 50
3.1.4 Commercial Kits 50
3.1.5 Consumables 50
3.1.6 Chemical Reagents 50
3.1.7 Equipments 51
3.2 Methods 53
3.2.1 Collection of Plant Samples 53
3.2.2 Preparation of Crude Aqueous Extracts 53
3.2.3 Preparation of Culture Media 55
3.2.4 Stock Cultures Preparation and Condition 55
3.2.5 Preparation of Standard Candida Cell Suspension 56
3.2.6 Screening of the Plant Extracts for Antifungal Response 56
3.2.6.1 The Kirby-Bauer Susceptibility Test 56
3.2.7 Screening for Antifungal Activity 57
3.2.7.1 Preparation of Candidal Suspension 57
3.2.7.2 Preparation of Extract’s Stock Solution 59
3.2.7.3 Determination of Minimum Inhibition Concentration 59
xiii
LIST OF CONTENTS PAGE
3.2.7.4 Determination of Minimum Fungicidal Concentration 61
3.2.8 The Effect of Brucea javanica L. and Piper betle L. Extracts 61
on the Growth Profiles of Candida Species
3.2.8.1 Experimental Design 61
3.2.8.2 Growth Profiles of Untreated Candida Species 62
3.2.8.3 Growth Profiles of Extract-treated Candida Species 62
3.2.9 The Effects of Brucea javanica L. and Piper betle L. Extracts 65
on the Cell Surface Hydrophobicity of Candida Species
3.2.9.1 Experimental Design 65
3.2.9.2 Preparation of Standard Candidal Cell Suspension 65
3.2.9.3 Determination of Cell Surface Hydrophobicity without 67
Treatment
3.2.9.4 Cell Surface Hydrophobicity of Candida Species 67
Following Treatment of the Extracts
3.2.10 The Effects of Brucea javanica L. and Piper betle L. Extracts 68
on the Adherence of Candida Species
3.2.10.1 Experimental Design 68
3.2.10.2 Collection of Saliva 69
3.2.10.3 Preparation of Acquired-pellicles 69
3.2.10.4 Adherence Affinities of Candida Species to Salivary 69
Pellicles
3.2.10.5 Anti-adherence Activity of Brucea javanica L. and 70
Piper betle L. Extracts
xiv
LIST OF CONTENTS PAGE
3.2.11 The Effects of Brucea javanica L. and Piper betle L. Extracts 72
on the Morphology of Candida Species
3.2.11.1 Experimental Design 72
3.2.11.2 Preparation of Samples for Scanning Electron Microscopy 72
3.2.12 The Effects of Brucea javanica L. and Piper betle L. Extracts 73
on the Expression of Secretory Aspartyl Proteinases (SAP1-10)
and Hyphal Wall Protein (HWP1) Genes
3.2.12.1 Experimental Design 73
3.2.12.2 Total RNA Extraction 75
3.2.12.3 RNA Quantification 76
3.2.12.4 Specific Primers 77
3.2.12.5 Reverse Transcription-Polymerase Chain Reaction 78
3.2.13 Statistical Analysis 79
CHAPTER FOUR: RESULTS
4.1 Screening of Plant Extracts for Antifungal Activity 80
4.1.1 The Kirby-Bauer Susceptibility Test 80
4.2 Determination of Antifungal Activity 84
4.3 The Effect of Brucea javanica L. and Piper betle L. Extracts on the 86
Growth Profiles of Candida Species
4.3.1 Growth Profiles of Candida Species 86
4.3.2 Growth Profiles of Candida Species Following Treatment of 92
Brucea javanica and Piper betle Extracts
xv
LIST OF CONTENTS PAGE
4.4 The Effect of Brucea javanica L. and Piper betle L. Extracts on the 102
Cell Surface Hydrophobicity of Candida Species
4.4.1 Cell Surface Hydrophobicity of Selected Oral Candida Species 102
4.4.2 Cell Surface Hydrophobicity of Selected Oral Candida Species 104
Following Treatment of Brucea javanica and Piper betle Extracts
4.5 The Effect of Brucea javanica L. and Piper betle L. Extracts on the 108
Adherence Affinity of Candida Species to Acquired Pellicles
4.5.1 The Adherence Affinity of Candida Species 108
4.5.2 Anti-adherence Activity of Brucea javanica and Piper betle 110
Extracts
4.6 The Effect of Brucea javanica L. and Piper betle L. Extracts on the 113
Morphology of Candida Species
4.6.1 Scanning Electron Microscope Examination 113
4.7 The Effect of Brucea javanica L. and Piper betle L. Extracts on the 129
Expressions of Secretory Aspartyl Proteinases (SAP1-10) and Hyphal
Wall Protein (HWP1) Genes
4.7.1 Differential Expression of Secretory Aspartyl Proteinases 129
(SAP1-10)
4.7.2 Differential Expression of Hyphal Wall Protein (HWP1) 130
CHAPTER FIVE: DISCUSSION
5.1 The Susceptibility of Oral Candida to Piper betle and Brucea javanica 134
Extracts
xvi
LIST OF CONTENTS PAGE
5.2 Growh Inhibitory Responses of Candida Species to Piper betle and 136
Brucea javanica Extracts
5.3 Adherence Capacity of Oral Candida Species: The Cell Surface 139
Hydrophobicity and Specific Adhesion Mechanism of Candidal Cells
under Influence of Brucea javanica and Piper betle Extracts
5.4 Ultrastructure of Candida Species Following Treatment with the 143
Piper betle and Brucea javanica Extracts
5.5 Differential Expression of SAP1-10 and HWP1 Genes Following 145
Treatment with the Piper betle and Brucea javanica Extracts
CHAPTER SIX: SUMMARY AND CONCLUSIONS
6.1 Summary and Conclusions 152
CHAPTER SEVEN: CLINICAL SIGNIFICANCE AND
RECOMMENDATIONS
7.1 Significance of the Study in Clinical Application 155
7.2 Recommendations for Future Research 156
REFERENCES 158
APPENDIX 193
xvii
LIST OF FIGURES PAGE
Figure 2.1 Chitin structure – a simple polysaccharide in the cell walls of all 11
fungi
Figure 2.2 Schematic representation of cell wall components 12
Figure 2.3 Schematic diagram summarizing the possible predisposing 25
factors influenced the interaction between Candida and the host
Figure 2.4 Brucea javanica Linn. 35
Figure 2.5 Centella asiatica Linn. 37
Figure 2.6 Garcinia mangostana Linn. 39
Figure 2.7 Mangifera indica Linn. 41
Figure 2.8 Piper betle Linn. 43
Figure 2.9 Piper sarmentosum Roxb. 45
Figure 2.10 Psidium guajava Linn. 47
Figure 3.1 An outline of the research procedures 54
Figure 3.2 An illustration of the screening method using the Kirby-Bauer 58
susceptibility test
Figure 3.3 An illustration of procedure to determine the MIC and MFC of 60
extracts against candidal species
Figure 3.4 An illustration of the growth kinetic assays 64
Figure 3.5 An illustration of determination of cell surface hydrophobicity of 66
candidal species
Figure 3.6 An illustration of the Nordini Artificial Mouth (NAM) model 71
Figure 3.7 An outline of the molecular study 74
Figure 4.1 The antifungal responses of Candida species using the 82
Kirby-Bauer susceptibility test
xviii
LIST OF FIGURES PAGE
Figure 4.2 Growth curve of Candida species cultured in YPD broth 87
Figure 4.3 A composite figure illustrating the normal growth of Candida 88
species cultured in YPD broth
Figure 4.4 Composite figures illustrating the population of Candida species 94
following treatment with P. betle extract
Figure 4.5 Composite figures illustrating the population of Candida species 97
following treatment with B. javanica extract
Figure 4.6 The cell surface hydrophobicity of Candida species measured by 103
their binding affinities to hexadecane
Figure 4.7 Comparison of the effect of P. betle and B. javanica extracts 106
on the CSH of oral candidal species
Figure 4.8 The adherence of candida to saliva-coated glass surface 109
Figure 4.9 The adhering capacity of oral candida to salivary-pellicle 111
(untreated) and extract-treated pellicle
Figure 4.10 The anti-adherence effect of P. betle and B. javanica extracts 112
on the binding capacity of oral Candida species to the acquired
pellicles
Figure 4.11 SEM micrographs of C. albicans 122
Figure 4.12 SEM micrographs of C. dubliniensis 123
Figure 4.13 SEM micrographs of C. glabrata 124
Figure 4.14 SEM micrographs of C. krusei 125
Figure 4.15 SEM micrographs of C. lusitaniae 126
Figure 4.16 SEM micrographs of C. parapsilosis 127
Figure 4.17 SEM micrographs of C. tropicalis 128
xix
LIST OF FIGURES PAGE
Figure 4.18 Differential expression of SAP1-10 genes in C. albicans 132
cultured in different conditions
Figure 4.19 Differential expression of HWP1 gene in C. albicans 133
cultured in different conditions
Figure 6.1 Summary of the effect of crude extract of B. javanica and 154
P. betle on oral candida
xx
LIST OF TABLES PAGE
Table 2.1 Virulence attributes of C. albicans 31
Table 3.1 Oligonucleotide sequences of SAP1-10 and ACT1 gene 77
Table 3.2 Oligonucleotide sequences of HWP1 gene 78
Table 4.1 The diameter of growth inhibition zones produced by the seven 83
plant extracts on the seven different Candida species
Table 4.2 MIC and MFC values of B. javanica and P. betle extracts 85
towards seven species of candida
Table 4.3 Changes in the doubling time (g) and specific growth rates (µ) 100
of the candidal species cultured in the absence (untreated) and
presence of P. betle extract (1, 3 and 6 mg/mL)
Table 4.4 Changes in the doubling time (g) and specific growth rates (µ) 101
of the candidal species cultured in the absence (untreated) and
presence of B. javanica extract (1, 3 and 6 mg/mL)
Table 4.5 The means percentage of adsorption of seven Candida species 107
to hexadecane following treatment with B. javanica and P. betle
extracts at different concentrations of 1, 3 and 6 mg/mL
Table 4.6 Deviations in the sizes of candidal cells following treatment of 114
P. betle and B. javanica extracts.
Table 4.7 The changes in the ultrastructural morphological features of 115
seven Candida species cells observed following treatment of
P. betle and B. javanica extracts (6 mg/mL)
xxi
LIST OF ABBREVIATIONS
Abbreviation Description
bp Base pair
cm Centimetre
CSH Cell surface hydrophobicity
CWP Cell wall protein
CHX Chlorhexidine gluconate
CFU/mL Colony forming units per millilitre
° C Degree Celsius
DNA Deoxyribonucleic acid
dNTP Deoxyribonucleoside triphosphates
dH2O Distilled water
EtBr Ethidium bromide
GPI Glycophophatidylinositol
g Gravity
g Gram
g/mL Gram per millilitre
g/L Gram per litre
h Hour(s)
L Litre
µg Microgram
μg/mL Microgram per millilitre
µL Microlitre
mL Millilitre
mL/min Millilitre per minute
xxii
LIST OF ABBREVIATIONS
Abbreviation Description
µL Microlitre
μm Micromolar
µmole/ml Micromoles per millilitre
mg Milligram
mg/mL Milligram per millilitre
mm Millimetre
mM Millimolar
min Minute
M Molar
MW Molecular weight
nm Nanometer
OD Optical density
pp. Pages
% Percentage
RT-PCR Reverse transcription-polymerase chain reaction
rDNA Ribosomal deoxynucleic acid
RNA Ribonucleic acid
RNase Ribonuclease
sec Seconds
NaCl Sodium chloride
sp. Species
i.e. That is
TBE Tris-Borate-EDTA
xxiii
LIST OF ABBREVIATIONS
Abbreviation Description
U/mL Unit per millilitre
V Voltage
v/v Volume per volume
w/v Weight per volume
YPD Yeast peptone dextrose